Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 10—October 2010

CME ACTIVITY

Changing Epidemiology of Pulmonary Nontuberculous Mycobacteria Infections

Rachel M. ThomsonComments to Author  and on behalf of the NTM working group at the Queensland TB Control CentreQueensland Mycobacterial Reference Laboratory
Author affiliation: Author affiliation: Queensland Tuberculosis Control Centre, Brisbane, Queensland, Australia

Main Article

Table 3

Clinical significance of nontuberculous mycobacteria isolates from pulmonary sites, Queensland, Australia, 2005*

Species Significant Under evaluation Not significant Total
Slow growers
Mycobacterium intracellulare 79 (39.7) 22 (11.1) 98 (49.2) 199
M. avium 18 (33.3) 8 (14.8) 28 (48.3) 54
MAC 3 (100) 3
M. kansasii 10 (52.6) 3 (15.8) 6 (31.6) 19
M. scrofulaceum 3 (30) 7 (70) 10
M. gordonae 2 (11.1) 16 (88.9) 18
M. lentiflavum 5 (100) 5
M. asiaticum 3 (100) 3
M. haemophilum 1 (100) 1
M. simiae 2 (100) 2
Unspeciated


24 (100)
24
Rapid growers
M. abscessus 7 (24.1) 4 (13.8) 18 (62.1) 29
M. chelonae 3 (21.4) 2 (14.3) 9 (64.3) 14
M. fortuitum 1 (5.3) 1 (5.3) 17 (89.4) 19
M. peregrinum 1 (33.3) 2 (66.7) 3
M. mucogenicum 2 (100) 2
M. nonchromogenicum 1 (50) 1 (50) 2
Unspeciated
2 (28.6)

5 (71.4)
7
Atypical mycobacteria NFI
5(7.0)
10 (14.1)
56 (78.9)
71
Other


3 (100)
3
Total 130 52 306 488

*Values are given as no. isolates (% of total for species). MAC, Mycobacterium avium complex; –, not applicable; NFI, not further identified.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO